Immediate Impact
58 standout
Citing Papers
Cystic fibrosis
2024 Standout
Circulating tumor cells: from new biological insights to clinical practice
2024 Standout
Works of Mark P. Murphy being referenced
Effect of elexacaftor/tezacaftor/ivacaftor on airway and systemic inflammation in cystic fibrosis
2023
Erlotinib or gefitinib for the treatment of relapsed platinum pretreated non-small cell lung cancer and ovarian cancer: A systematic review
2011
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Mark P. Murphy | 147 | 56 | 60 | 100 | 27 | 398 | |
| Yoshiko Naito | 107 | 99 | 68 | 145 | 33 | 440 | |
| Chao Sun | 33 | 58 | 39 | 90 | 35 | 370 | |
| René J. Boosman | 100 | 129 | 38 | 80 | 31 | 428 | |
| Hozumi Yamada | 196 | 43 | 16 | 47 | 40 | 422 | |
| David Schneberger | 87 | 23 | 24 | 71 | 26 | 458 | |
| Eduardo Reyes | 72 | 39 | 22 | 95 | 23 | 423 | |
| Changyin Wang | 71 | 78 | 42 | 80 | 43 | 452 | |
| S. W. A. Kuper | 55 | 51 | 12 | 95 | 23 | 408 | |
| Qizhi Cao | 50 | 46 | 32 | 85 | 24 | 365 | |
| Anna Kołodziej | 104 | 56 | 18 | 43 | 42 | 441 |
All Works
Login with ORCID to disown or claim papers
Loading papers...